GILEAD SCIENCES, INC. Buildings and Improvements, Gross
GILEAD SCIENCES, INC. (GILD) had Buildings and Improvements, Gross of $4.62 billion as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:BuildingsAndImprovementsGross · last filed 2026-02-24
- 2025-12-31: Buildings and Improvements, Gross $4.62B.
- 2024-12-31: Buildings and Improvements, Gross $4.54B.
- 2023-12-31: Buildings and Improvements, Gross $4.33B.
- 2022-12-31: Buildings and Improvements, Gross $4.39B.
| Period end | Buildings and Improvements, Gross | Buildings and Improvements, Gross as first filed |
|---|---|---|
| 2025-12-31 | $4.62B 10-K · filed 2026-02-24 | |
| 2024-12-31 | $4.54B 10-K · filed 2026-02-24 | |
| 2023-12-31 | $4.33B 10-K · filed 2025-02-28 | |
| 2022-12-31 | $4.39B 10-K · filed 2024-02-23 | |
| 2021-12-31 | $3.79B 10-K · filed 2023-02-22 | |
| 2020-12-31 | $3.68B 10-K · filed 2022-02-23 | |
| 2019-12-31 | $3.36B 10-K · filed 2021-02-25 | |
| 2018-12-31 | $2.34B 10-K · filed 2020-02-25 | |
| 2017-12-31 | $2.18B 10-K · filed 2019-02-26 | |
| 2016-12-31 | $1.71B 10-K · filed 2018-02-27 | |
| 2015-12-31 | $1.32B 10-K · filed 2017-02-27 | |
| 2014-12-31 | $997.00M 10-K · filed 2016-02-24 | |
| 2013-12-31 | $835.00M 10-K · filed 2015-02-25 | $834.91M 10-K · filed 2014-02-25 |
| 2012-12-31 | $670.47M 10-K · filed 2014-02-25 | |
| 2011-12-31 | $500.04M 10-K · filed 2013-02-27 | |
| 2010-12-31 | $501.40M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |